Stanozolol is a derivative of dihydrotestosterone, chemically altered so that the hormone’s anabolic (tissue-building) properties are greatly amplified and its androgenic activity is minimized. Stanozolol is classified as an anabolic steroid, and exhibits one of the strongest dissociations of anabolic to androgenic effect among the commercially available agents. It also cannot be aromatized into estrogens. Stanozolol is favored for its ability to promote muscle growth without water-retention, making it highly valued by dieting bodybuilders and competitive athletes. Stanozolol differs from DHT by the addition of a methyl group on carbon 17alpha to protect the hormone during oral administration and the attachment of a pyrazol group to the A-ring, replacing the normal 3-keto group (this gives Stanozolol the chemical classification of a heterocyclic steroid). The A-ring modification of Stanozolol increases considerably its anabolic strength while reducing its relative androgenity.
Stanozolol is synthetic steroid having both anabolic and androgenic properties. The injectable form of Stanozolol is a water based anabolic steroid that is derived from DHT(Dihydrotestosterone)
Unlike most injectable anabolic steroids, Stanozolol is not esterified and is available as an aqueous suspension or in oral tablet form. This means that it does not have a classical decay half-life. The drug has a large oral bioavailability, due to a C17 a-alkylation, which allows the hormone to survive first pass liver metabolism when ingested. It can be toxic to the liver upon excessive intake or overdose. Very few users report water retention or any other side effects.
Indications and Usage
In humans it is used for treatment of anemia and hereditary angioedema which causes episodes of swelling of the face, extremities, genitals, bowel wall, and throat. Stanozolol is one of the anabolic steroids commonly used as an ergogenic aid and is banned from use in sports competition under the auspices of the International Association of Athletics Federations (IAAF).
Contraindicated in prostate carcinoma, male breast carcinoma, liver and kidney dysfunction and in hypercalcemia, pregnancy, lactating mothers.
Stanozolol should not be used in the patients with known hypersensitivity to it or any other excipients.
Dosage and administration
Stanozolol injections should be administered intramuscularly Men: 100-200 mg per week
Women: 25 50 mg per week
Shake gently before use.
Anabolic steroids have the potential capacity of generating masculinizing effects, which can disturb the feminine appearance. If this happens, the treatment must be strictly controlled by the doctor. Long term treatment to promote the growth must be interrupted when the skeletal age (to be controlled by radiology every 6 months) approaches the chronological age. Athletes should be informed that this product contains a component that gives a positive analytical result in doping control.
Oral Anticoagulants (blood thinners). Stanozolol enhances effects of anticoagulants and thus causes excessive bleeding.
Oral hypoglycemic agent and insulin. Stanozolol can decrease blood sugar level and insulin in diabetic patients.
Corticosteroids. Tendency towards edema is enhanced, use with caution in patients with hepatic or cardiac disease.
Enzyme-inducing agents may increase or decrease testosterone levels Therefore, adjustment of the dose, and/or intervals between administrations may be required. Caution should be taken when administering Stanozolol to patients with a history of myocardial infarction or coronary artery disease as androgens may alter serum cholesterol concentrations.
Female – Women should normally avoid Stanozolol intake since it could result in unpleasant androgen- linked side effects such as virilization including deepening of voice and clitoral enlargement, amenorrhea, menstrual irregularities, many females experience acne vulgaris.
Male-Gynecomastia, oligospermia at higher doses and excessive frequency and duration of penile erection.
Other non-androgenic side effects can occur in both sexes: in headaches, cramps, changes in the HDL and LDL values, and in rare cases, in high blood pressure. When Stanozolol is administered liver damage can be estimated as very low possibility. However, an elevation of liver enzymes is possible in large doses. Stanozolol suspension injections are more uncomfortable or more painful usually than oil-based solutions.
If overdose of Stanozolol is suspected, contact your local poison control center or emergency room immediately.
Store below 25 C. Do not refrigerate (or freeze). Store away from moisture, heat, and direct light.
1x10ml glass vial